Published in World J Gastroenterol on November 07, 2015
Sweet Taste Receptor TAS1R2 Polymorphism (Val191Val) Is Associated with a Higher Carbohydrate Intake and Hypertriglyceridemia among the Population of West Mexico. Nutrients (2016) 0.77
CD36 genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection. World J Hepatol (2016) 0.75
Early Detection of Liver Damage in Mexican Patients with Chronic Liver Disease. J Transl Int Med (2017) 0.75
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology (2007) 26.78
Hepatocellular carcinoma. Lancet (2012) 18.09
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (2013) 12.46
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet (2008) 10.87
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem (2000) 9.07
Senescence of activated stellate cells limits liver fibrosis. Cell (2008) 8.98
Human fatty liver disease: old questions and new insights. Science (2011) 8.03
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med (2010) 6.45
Liver cirrhosis. Lancet (2008) 6.11
Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol (2010) 5.87
Hepatitis B virus infection. Lancet (2009) 5.78
Alcoholic liver disease. Hepatology (2010) 5.04
Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol (2007) 4.73
The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol (2013) 4.05
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J (2012) 3.37
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia (2009) 3.33
Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol (2013) 3.25
Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet (2009) 3.24
Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology (1998) 3.13
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology (2010) 3.11
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology (2010) 2.95
Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol (2011) 2.82
The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology (2010) 2.75
A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res (2009) 2.75
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol (2004) 2.66
Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol (2004) 2.46
Liver cirrhosis. Lancet (2014) 2.45
Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol (2009) 2.45
Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol (1999) 2.34
Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J (2005) 2.34
Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis. Hum Mol Genet (2008) 2.26
TGF-β in progression of liver disease. Cell Tissue Res (2011) 2.22
Hepatitis E virus infection. Clin Microbiol Rev (2014) 2.21
Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology (2001) 1.90
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. J Hepatol (2010) 1.86
An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J (2008) 1.83
Pathophysiology of hepatitis C virus infection and related liver disease. Trends Microbiol (2004) 1.75
Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. Hepatology (2005) 1.74
Natural history of hepatitis C. J Hepatol (2014) 1.73
Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology (2006) 1.68
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med (2014) 1.66
Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia (2005) 1.64
Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry (2007) 1.56
Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg (2005) 1.52
Genetic determinants of hepatic steatosis in man. J Lipid Res (2011) 1.52
Epigenetics: A New Bridge between Nutrition and Health. Adv Nutr (2010) 1.51
What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol (2012) 1.50
Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology (2011) 1.49
Alcohol dehydrogenase and alcohol dependence: variation in genotype-associated risk between populations. Am J Hum Genet (2002) 1.47
Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. Am J Physiol Cell Physiol (2013) 1.42
Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol (2010) 1.40
HCV and oxidative stress in the liver. Viruses (2013) 1.28
Fructose as a key player in the development of fatty liver disease. World J Gastroenterol (2013) 1.26
Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol (2014) 1.25
Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology (2002) 1.24
Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clin Mol Hepatol (2013) 1.23
Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology (2004) 1.23
Obesity prevalence in Mexico: impact on health and economic burden. Public Health Nutr (2013) 1.23
Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs (2005) 1.17
The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population. J Hepatol (2007) 1.17
Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. Curr Pharm Des (2013) 1.16
Alcoholic liver disease. World J Hepatol (2012) 1.16
PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Liver Int (2011) 1.16
Molecular basis of hepatic fibrosis. Expert Rev Mol Med (2003) 1.14
Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol (2012) 1.13
Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. Gut (2005) 1.11
Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin. Aliment Pharmacol Ther (2012) 1.11
Innate immune responses in hepatitis B virus (HBV) infection. Virol J (2014) 1.11
HCV routes of transmission: what goes around comes around. Semin Liver Dis (2011) 1.10
Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int (2011) 1.10
Diagnosis and epidemiology of cirrhosis. Med Clin North Am (2009) 1.10
Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. Hepatology (2008) 1.09
Cellular and molecular mechanisms in liver fibrogenesis. Arch Biochem Biophys (2014) 1.08
Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes. Diabetologia (2000) 1.07
Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. Eur J Endocrinol (2009) 1.06
Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World J Gastroenterol (2014) 1.06
Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease. Liver Int (2009) 1.04
Polymorphisms of MRP2 (ABCC2) are associated with susceptibility to nonalcoholic fatty liver disease. J Nutr Biochem (2008) 1.03
Chronic HCV infection: epidemiological and clinical relevance. BMC Infect Dis (2012) 1.02
The molecular virology of hepatitis B virus. Semin Liver Dis (2013) 1.01
A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review. Hepatol Int (2008) 1.01
Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. World J Gastroenterol (2010) 1.00
Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol (2014) 1.00
Pathogenesis of liver cirrhosis. World J Gastroenterol (2014) 0.99
Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease. Cytokine (2008) 0.99
Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. World J Gastroenterol (2005) 0.99
Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population. J Med Virol (2010) 0.98
The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment. Sci Rep (2015) 0.98
Genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 and liver cirrhosis, chronic calcific pancreatitis, diabetes mellitus, and hypertension among Japanese alcoholic men. Alcohol Clin Exp Res (2013) 0.98
Elevated hepatic iron: a confounding factor in chronic hepatitis C. Biochim Biophys Acta (2009) 0.97
Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol (2014) 0.97
Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Ann Hepatol (2004) 0.96
Immunologic, metabolic and genetic factors in hepatitis C virus infection. World J Gastroenterol (2014) 0.96
Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol (2008) 0.96
Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease. J Gastroenterol Hepatol (2009) 0.95
Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients. Cytokine (2012) 0.95
Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Dig Liver Dis (2003) 0.95
Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. J Gastroenterol (2009) 0.95
Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. J Gastroenterol Hepatol (2005) 0.94